Biomedical Research Education & Training
Faculty Member

Sahasrabuddhe, Vikrant V., M.B.B.S., M.P.H., Dr.P.H.
Research Associate Professor of Medicine

Lab Url: N/A

Phone Number: +1-240-276-7332

Email Address: vikrant.sahasrabuddhe@nih.gov

Sahasrabuddhe, Vikrant's picture
Academic history
N/AN/AN/AN/A

Office Address   Mailing Address

9609 Medical Center Drive, 5E-338, Rockville, Maryland 20850

NCI/NIH address: 9609 Medical Center Drive, 5E-338, Bethesda, Maryland 20892-9783 (for US Postal Service delivery), Rockville, Maryland 20850 (for non-USPS courier delivery and campus visits)


Research Keywords
Cancer Prevention, Cancer Epidemiology, Infection-associated Cancers, Cervical Cancer, HPV, Anogenital Cancers, Global Health

Clinical Research Keywords
Cancer Prevention, Cancer Epidemiology, Infection-associated Cancers, Cervical Cancer, HPV, Anogenital Cancers, Global Health

Clinical Research Description
Dr. Vikrant Sahasrabuddhe is now based as Program Director in the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH)


Publications
Kreimer, AR, Sherman, ME, Sahasrabuddhe, VV, Safaeian, M. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. J Natl Cancer Inst, 107(3), dju436, 2015

McCree, R, Giattas, MR, Sahasrabuddhe, VV, Jolly, PE, Martin, MY, Usdan, SL, Kohler, C, Lisovicz, N. Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up. Oncologist, Epub ahead of print, 2015

McGlynn, KA, Hagberg, K, Chen, J, Graubard, BI, London, WT, Jick, S, Sahasrabuddhe, VV. Statin use and risk of primary liver cancer in the clinical practice research datalink. J Natl Cancer Inst, 107(4), djv009, 2015

McGlynn, KA, Sahasrabuddhe, VV, Campbell, PT, Graubard, BI, Chen, J, Schwartz, LM, Petrick, JL, Alavanja, MC, Andreotti, G, Boggs, DA, Buring, JE, Chan, AT, Freedman, ND, Gapstur, SM, Hollenbeck, AR, Hou, L, King, LY, Koshiol, J, Linet, M, Palmer, JR, Poynter, JN, Purdue, M, Robien, K, Schairer, C, Sesso, HD, Sigurdson, A, Wactawski-Wende, J, Zeleniuch-Jacquotte, A. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project. Br J Cancer(/), Epub ahead of print, 2015

Parham, GP, Mwanahamuntu, MH, Kapambwe, S, Muwonge, R, Bateman, AC, Blevins, M, Chibwesha, CJ, Pfaendler, KS, Mudenda, V, Shibemba, AL, Chisele, S, Mkumba, G, Vwalika, B, Hicks, ML, Vermund, SH, Chi, BH, Stringer, JS, Sankaranarayanan, R, Sahasrabuddhe, VV. Population-Level Scale-Up of Cervical Cancer Prevention Services in a Low-Resource Setting: Development, Implementation, and Evaluation of the Cervical Cancer Prevention Program in Zambia. PLoS One, 10(4), e0122169, 2015

Bateman, AC, Parham, GP, Sahasrabuddhe, VV, Mwanahamuntu, MH, Kapambwe, S, Katundu, K, Nkole, T, Mulundika, J, Pfaendler, KS, Hicks, ML, Shibemba, A, Vermund, SH, Stringer, JS, Chibwesha, CJ. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr, 67(2), 212-5, 2014

Hagberg, KW, McGlynn, KA, Sahasrabuddhe, VV, Jick, S. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes. Br J Cancer, 111(9), 1710-7, 2014

McGlynn, KA, Divine, GW, Sahasrabuddhe, VV, Engel, LS, VanSlooten, A, Wells, K, Yood, MU, Alford, SH. Statin use and risk of hepatocellular carcinoma in a U.S. population. Cancer Epidemiol, 38(5), 523-7, 2014

Mwanahamuntu, MH, Sahasrabuddhe, VV, Blevins, M, Kapambwe, S, Shepherd, BE, Chibwesha, C, Pfaendler, KS, Mkumba, G, Vwalika, B, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. Monitoring the performance of 'screen-and-treat' cervical cancer prevention programs. Int J Gynaecol Obstet, 126(1), 88-9, 2014

Sahasrabuddhe, VV, Gravitt, PE, Dunn, ST, Brown, D, Allen, RA, Eby, YJ, Smith, K, Zuna, RE, Zhang, RR, Gold, MA, Schiffman, M, Walker, JL, Castle, PE, Wentzensen, N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol, 52(1), 187-92, 2014

Sahasrabuddhe, VV, Gravitt, PE, Dunn, ST, Robbins, D, Brown, D, Allen, RA, Eby, YJ, Smith, KM, Zuna, RE, Zhang, RR, Gold, MA, Schiffman, M, Walker, JL, Castle, PE, Wentzensen, N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol, 60(4), 414-7, 2014

Wentzensen, N, Follansbee, S, Borgonovo, S, Tokugawa, D, Sahasrabuddhe, VV, Chen, J, Lorey, TS, Gage, JC, Fetterman, B, Boyle, S, Sadorra, M, Tang, SD, Darragh, TM, Castle, PE. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. J Clin Microbiol, 52(8), 2892-7, 2014

Wilson, L, Pawlita, M, Castle, PE, Waterboer, T, Sahasrabuddhe, V, Gravitt, PE, Schiffman, M, Wentzensen, N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. J Infect Dis, 210(3), 448-55, 2014

Zhang, HY, Fei, MD, Jiang, Y, Fei, QY, Qian, H, Xu, L, Jin, YN, Jiang, CQ, Li, HX, Tiggelaar, SM, Smith, JS, Sahasrabuddhe, VV, Qiao, YL. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Virol J, 11(1), 202, 2014

Chen, Z, Schiffman, M, Herrero, R, DeSalle, R, Anastos, K, Segondy, M, Sahasrabuddhe, VV, Gravitt, PE, Hsing, AW, Burk, RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One, 8(8), e72565, 2013

De Vuyst, H, Alemany, L, Lacey, C, Chibwesha, CJ, Sahasrabuddhe, V, Banura, C, Denny, L, Parham, GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine, 31 Suppl 5, F32-46, 2013

Godfrey, CC, Michelow, PM, Godard, M, Sahasrabuddhe, VV, Darden, J, Firnhaber, CS, Wetherall, NT, Bremer, J, Coombs, RW, Wilkin, T, , . Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks. Am J Clin Pathol, 140(6), 881-9, 2013

Mwanahamuntu, MH, Sahasrabuddhe, VV, Blevins, M, Kapambwe, S, Shepherd, BE, Chibwesha, C, Pfaendler, KS, Mkumba, G, Vwalika, B, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. Utilization of cervical cancer screening services and trends in screening positivity rates in a ''screen-and-treat'' program integrated with HIV/AIDS care in Zambia. PLoS One, 8(9), e74607, 2013

Sahasrabuddhe, VV, Castle, PE, Follansbee, S, Borgonovo, S, Tokugawa, D, Schwartz, LM, Lorey, TS, LaMere, BJ, Gage, JC, Fetterman, B, Boyle, S, Sadorra, M, Tang, SD, Darragh, TM, Wentzensen, N. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis, 207(3), 392-401, 2013

Sahasrabuddhe, VV, Gunja, MZ, Graubard, BI, Trabert, B, Schwartz, LM, Park, Y, Hollenbeck, AR, Freedman, ND, McGlynn, KA. Response. J Natl Cancer Inst, 105(9), 668- 71, 2013

Schwartz, LM, Castle, PE, Follansbee, S, Borgonovo, S, Fetterman, B, Tokugawa, D, Lorey, TS, Sahasrabuddhe, VV, Luhn, P, Gage, JC, Darragh, TM, Wentzensen, N. Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis, 208(11), 1768-75, 2013

Wilson, LE, Pawlita, M, Castle, PE, Waterboer, T, Sahasrabuddhe, V, Gravitt, PE, Schiffman, M, Wentzensen, N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer, 133(9), 2172-81, 2013

Brinton, LA, Sahasrabuddhe, VV, Scoccia, B. Fertility drugs and the risk of breast and gynecologic cancers. Semin Reprod Med, 30(2), 131-45, 2012

Mane, A, Nirmalkar, A, Risbud, AR, Vermund, SH, Mehendale, SM, Sahasrabuddhe, VV. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS One, 7(6), e38731, 2012

Sahasrabuddhe, VV, Bhosale, RA, Kavatkar, AN, Nagwanshi, CA, Joshi, SN, Jenkins, CA, Shepherd, BE, Kelkar, RS, Sahay, S, Risbud, AR, Vermund, SH, Mehendale, SM. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer, 130(1), 234-40, 2012

Sahasrabuddhe, VV, Gunja, MZ, Graubard, BI, Trabert, B, Schwartz, LM, Park, Y, Hollenbeck, AR, Freedman, ND, McGlynn, KA. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst, 104(23), 1808-14, 2012

Sahasrabuddhe, VV, Parham, GP, Mwanahamuntu, MH, Vermund, SH. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila), 5(1), 11-7, 2012

Sahasrabuddhe, VV, Sherman, ME. Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. J Natl Cancer Inst, 104(22), 1698-701, 2012

Sahasrabuddhe, VV, Shiels, MS, McGlynn, KA, Engels, EA. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer, 118(24), 6226-33, 2012

Wentzensen, N, Follansbee, S, Borgonovo, S, Tokugawa, D, Schwartz, L, Lorey, TS, Sahasrabuddhe, VV, Lamere, B, Gage, JC, Fetterman, B, Darragh, TM, Castle, PE. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS, 26(17), 2185-92, 2012

Zhang, HY, Tiggelaar, SM, Sahasrabuddhe, VV, Smith, JS, Jiang, CQ, Mei, RB, Wang, XG, Li, ZA, Qiao, YL. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev, 13(1), 91-6, 2012

Chen, Z, Schiffman, M, Herrero, R, Desalle, R, Anastos, K, Segondy, M, Sahasrabuddhe, VV, Gravitt, PE, Hsing, AW, Burk, RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One, 6(5), e20183, 2011

Mwanahamuntu, MH, Sahasrabuddhe, VV, Kapambwe, S, Pfaendler, KS, Chibwesha, C, Mkumba, G, Mudenda, V, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med, 8(5), e1001032, 2011

Sahasrabuddhe, VV, Luhn, P, Wentzensen, N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol, 6(9), 1083-98, 2011

Bratcher, LF, Sahasrabuddhe, VV. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer, 5, 8, 2010

Chirwa, S, Mwanahamuntu, M, Kapambwe, S, Mkumba, G, Stringer, J, Sahasrabuddhe, V, Pfaendler, K, Parham, G. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot, 17(2 Suppl), 47-50, 2010

Parham, GP, Mwanahamuntu, MH, Pfaendler, KS, Sahasrabuddhe, VV, Myung, D, Mkumba, G, Kapambwe, S, Mwanza, B, Chibwesha, C, Hicks, ML, Stringer, JS. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis, 14(3), 167-73, 2010

Parham, GP, Mwanahamuntu, MH, Sahasrabuddhe, VV, Westfall, AO, King, KE, Chibwesha, C, Pfaendler, KS, Mkumba, G, Mudenda, V, Kapambwe, S, Vermund, SH, Hicks, ML, Stringer, JS, Chi, BH. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther, 4(6), 703-722, 2010

Sahasrabuddhe, VV, Bhosale, RA, Joshi, SN, Kavatkar, AN, Nagwanshi, CA, Kelkar, RS, Jenkins, CA, Shepherd, BE, Sahay, S, Risbud, AR, Vermund, SH, Mehendale, SM. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One, 5(1), e8634, 2010

Li, AH, Phanuphak, N, Sahasrabuddhe, VV, Chaithongwongwatthana, S, Vermund, SH, Jenkins, CA, Shepherd, BE, Teeratakulpisarn, N, van der Lugt, J, Avihingsanon, A, Ruxrungtham, K, Shikuma, C, Phanuphak, P, Ananworanich, J. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Sex Transm Infect, 85(7), 503-7, 2009

Mwanahamuntu, MH, Sahasrabuddhe, VV, Parham, GP. HPV screening for cervical cancer in rural India. N Engl J Med, 361(3), 305; author reply 306, 2009

Mwanahamuntu, MH, Sahasrabuddhe, VV, Pfaendler, KS, Mudenda, V, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. Implementation of ''see-and-treat'' cervical cancer prevention services linked to HIV care in Zambia. AIDS, 23(6), N1-5, 2009

Sahasrabuddhe VV, Vermund SH. Current And Future Trends: Implications For HIV Prevention. Book Chapter in Mayer KH, Pizer HF (editors) , 2009

Joshi, SN, Das, S, Thakar, M, Sahasrabuddhe, V, Kumar, BK, Callahan, M, Mauck, C. Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle. J Low Genit Tract Dis, 12(4), 293-9, 2008

Mwanahamuntu, MH, Sahasrabuddhe, VV, Stringer, JS, Parham, GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ, 86(8), D-E, 2008

Parham GP, Mwanahamuntu MH, Pfaendler KS, Mkumba G, Sahasrabuddhe VV, Hicks ML, Welty E, Stringer JS. Building a cervical cancer prevention program on an HIV care and treatment infrastructure in Zambia. Book chapter in Marlink RG, Teitelman SJ (editors) , 2008

Pfaendler, KS, Mwanahamuntu, MH, Sahasrabuddhe, VV, Mudenda, V, Stringer, JS, Parham, GP. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol, 110(3), 402-7, 2008

Sahasrabuddhe VV, Tharpe LE, Allen KL, Vermund SH. Public health interventions to prevent HIV: treatment of sexually transmitted infections and adult male circumcision. Book chapter in Marlink RG, Teitelman SJ (editors) (/), 2008

Vermund, SH, Sahasrabuddhe, VV, Khedkar, S, Jia, Y, Etherington, C, Vergara, A. Building global health through a center-without-walls: the Vanderbilt Institute for Global Health. Acad Med, 83(2), 154-64, 2008

Vikrant Sahasrabuddhe and Sanjay Mehendale . Female sex workers and the HIV/AIDS Epidemic in India. Book chapter in Sahni R, Kalyan Shankar V, Apte H (editors) , 2008

Sahasrabuddhe, VV, Mwanahamuntu, MH, Vermund, SH, Huh, WK, Lyon, MD, Stringer, JS, Parham, GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer, 96(9), 1480-3, 2007

Sahasrabuddhe, VV, Vermund, SH. The future of HIV prevention: control of sexually transmitted infections and circumcision interventions. Infect Dis Clin North Am, 21(1), 241-57, xi, 2007

Parham, GP, Sahasrabuddhe, VV, Mwanahamuntu, MH, Shepherd, BE, Hicks, ML, Stringer, EM, Vermund, SH. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol, 103(3), 1017-22, 2006

Sahasrabuddhe, V, Makhija, S. Double jeopardy: HIV and cervical cancer in Indian women. Int J Gynecol Cancer, 15(1), 1-3, 2005

Sahasrabuddhe, VV, Gholap, TA, Jethava, YS, Joglekar, NS, Brahme, RG, Gaikwad, BA, Wankhede, AK, Mehendale, SM. Patient-led partner referral in a district hospital based STD clinic. J Postgrad Med, 48(2), 105-8, 2002


Postdoctoral Position Available
N/A

Postdoctoral Position Details
N/A

Updated Date
06/27/2015